Business Wire

Philip Morris International Announces New Regional Structure and Senior Management Changes to Accelerate Growth Toward a Smoke-Free Future

Share

Philip Morris International Inc. (PMI) (NYSE: PM) today announced a new regional structure and related senior management changes to enable continued growth as a multicategory leader internationally and advance its rapid transition toward a smoke-free future.

“We are changing the company’s regional structure to further support the growth of our smoke-free business, reinforce consumer centricity, and increase the speed of innovation and deployment—all in alignment with our ambition of becoming a majority smoke-free business by net revenues by 2025,” said Jacek Olczak, PMI’s Chief Executive Officer. “The new structure will also create new opportunities to further grow our senior talent, deepening the bench of leaders who will spearhead PMI’s progress toward a smoke-free future for the years to come. I am confident of the exceptional caliber and determination of our people and wish them the best in their new roles.”

By the end of January 2023, PMI will rearrange its operations in four regions, down from the current six, under the leadership of the following members of senior management:

  • Paul Riley, currently President, East Asia & Australia Region, will be appointed President, East Asia, Australia, and PMI Duty Free Region;
  • Frederic de Wilde, currently President, European Union Region, will be appointed President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region;
  • Massimo Andolina, currently Senior Vice President, Operations, will be appointed President, Europe Region; and
  • Deepak Mishra, who will continue as President, Americas Region.

Drago Azinovic, currently President, Middle East and Africa and PMI Duty Free Region, will leave the organization after a transition period.

In addition, the following appointments will also take effect:

  • Marco Mariotti, currently President, Eastern Europe Region, will be appointed President, CIS, Central Asia & Israel, reporting into Frederic de Wilde;
  • Stacey Kennedy, currently President, South and Southeast Asia Region, will be appointed Chief Executive Officer of PMI’s U.S. business, reporting to Deepak Mishra; and
  • Scott Coutts, currently Vice President, Global Manufacturing, will be appointed Senior Vice President, Operations, succeeding Massimo Andolina and reporting into Jacek Olczak.

The new regional structure better aligns with the business strategy in the approximately 180 markets where PMI’s products are sold. It is designed to accelerate smoke-free product growth in markets where IQOS already holds double-digit market shares, while also driving the transition from cigarettes to smoke-free products in untapped markets—including as of April 2024, the U.S., the world’s largest smoke-free market as described in our recent press release.

Furthermore, the new regional structure will further support PMI’s efforts to broaden access to smoke-free products worldwide for those adults who would otherwise continue to smoke, including in low and middle income markets, which the company aspires to account for at least half of the markets where its smoke-free products will be available by 2025. Each region will comprise individual markets, as well as clusters of markets, and will provide opportunities to accelerate career development within PMI’s diverse talent pipeline.

The company’s quarterly results’ reporting and related filings will reflect the new regional structure as of Q1 2023.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the U.S. Since 2008, PMI has invested more than USD 9 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The U.S. Food and Drug Administration (FDA) has authorized the marketing of versions of PMI’s IQOS Platform 1 devices and consumables as a Modified Risk Tobacco Products (MRTPs), finding that an exposure modification orders for these products are appropriate to promote the public health. As of September 30, 2022, excluding Russia and Ukraine, PMI's smoke-free products are available for sale in 70 markets, and PMI estimates that approximately 13.5 million adults around the world had already switched to IQOS and stopped smoking. With a strong foundation and significant expertise in life sciences, in February 2021, PMI announced its ambition to expand into wellness and healthcare areas and deliver innovative products and solutions that aim to address unmet consumer and patient needs. For more information, please visit www.pmi.com and www.pmiscience.com

Forward-Looking and Cautionary Statements

This press release contains projections of future results and goals and other forward-looking statements, including statements regarding business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.

PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of COVID-19 on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; or if it is unable to attract and retain the best global talent, including women or diverse candidates. Future results are also subject to the lower predictability of our reduced-risk product category's performance.

In addition, important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties related to: the agreement with Altria and the benefits of the transaction; the possibility that expected benefits related to recent or pending acquisitions, including the transaction with Swedish Match, may not materialize as expected; the proposed transaction with Swedish Match not being timely completed; Swedish Match’s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, customers, licensees, other business partners or governmental entities; difficulty retaining key Swedish Match employees; the outcome of any legal proceedings related to the proposed transaction with Swedish Match; and the parties being unable to successfully implement integration strategies or to achieve expected synergies and operating efficiencies within the expected time-frames or at all.

PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2021 and the Form 10-Q for the quarter ended September 30, 2022. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.

# # #

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Philip Morris International
David Fraser
T. +41 (0)58 242 4500
E. David.Fraser@pmi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health1.2.2023 15:00:00 EET | Press release

Sampled1 today announced that the new genomics Sampled SMART Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc., a leading precision oncology company, to manage blood samples for a large-scale lung cancer screening study. The SHIELD Lung registrational study is designed to evaluate the performance of a Guardant blood-based screening test to detect lung cancer in high-risk individuals aged 50-80. Sampled has already begun receiving blood samples for the study, which is expected to enroll nearly 10,000 patients and will be conducted across approximately 100 centers in the U.S. and Europe. Sampled will manage receipt of the study’s blood samples from these test sites, prepare them for analysis, and store them until they are ready to be shipped to Guardant Health’s U.S. laboratories for test processing. “This project is a major milestone towards making Sampled’s world-class capabilities available around the world. Guardant Health is a leader in precision oncology testin

All Seas Capital Closes Maiden Fund With US$400m AUM1.2.2023 14:03:00 EET | Press release

All Seas Capital, a pan-European private capital fund that provides transformational capital solutions to leading founder- and entrepreneur-owned companies, is pleased to announce the final close of its maiden fund, All Seas Capital I SCSp (the “Fund”), with total commitments of US$400m including coinvestments. All Seas Capital’s global investor base, consisting of pension funds, sovereign wealth funds, consultants, insurance companies and banks from the US, Europe and Asia, provide a well-diversified mix of investors. Since inception to the Fund’s final close, All Seas Capital invested over US$200 million in portfolio companies, including Attivo Group (UK), Hakim Group (UK), SoMeD Santé (France) and Zimmer MedizinSysteme (Germany). All Seas Capital provides flexible long-term financing solutions to leading Western European mid-market businesses. Alongside transformational capital solutions, the All Seas team provides board level expertise to entrepreneurs and management teams who do n

ALECSO to Partner With SNC to Launch First Conference on International Organizations of Education, Science and Culture1.2.2023 13:57:00 EET | Press release

The Arab League Educational, Cultural and Scientific Organization (ALECSO), in cooperation with the Saudi National Commission for Education, Culture and Science (SNC), is set to host the inaugural edition of a major international conference on culture, science and education in the 21st century. The conference, ‘Future of Education, Science, and Culture International Organizations Forum’ (FESCIOF) will take place over two days from March 8-9, 2023, at the King Abdullah Petroleum Studies and Research Center (KAPSARC) in the Saudi capital Riyadh, with the participation of a number of major international organizations in the fields of education, culture and science. FESCIOF will host an unprecedented gathering of international organizations and global entities across a variety of sectors with the goal of enabling collaboration and facilitating cross-sectoral dialogue. Expected attendees include top international and multilateral organizations; regional institutions; national and regional p

Energy Aspects Acquires OilX, a Pioneer in AI Driven Data Analytics for Energy Markets1.2.2023 13:52:00 EET | Press release

Leading energy and macro research consultancy Energy Aspects has acquired OilX, a pioneer in AI-driven energy data analytics. The acquisition will enhance Energy Aspects’ insights as OilX’s real-time data technology complements Energy Aspects’ forward-looking analysis. OilX, in turn, will benefit from Energy Aspects’ proprietary data sets and world-class subject matter experts, improving its data-driven insights to clients. Founded in 2018 by Dr. Florian Thaler , OilX’s unique real-time energy market platform offers sophisticated ‘nowcasting’ capabilities, enabling its clients to understand energy markets as they evolve. OilX’s advanced technology utilises AI, satellite and tanker tracking data to create highly valuable proprietary data sets, and its UX design delivers high data usability. OilX’s product range covers crude oil, refined products, biofuels and NGL’s. Their platform, the world’s first real-time oil supply and demand balance, provides users with market analysis ahead of of

Major Update: B2Broker Adds Match-Trader White Label1.2.2023 13:00:00 EET | Press release

After integrating cTrader in 2022, B2Broker has continued to expand, with the integration of Match-Trader being the most recent. By adding Match-Trader, B2Broker, a worldwide provider of liquidity and technology for the FX and cryptocurrency markets, has announced the extension of its white label liquidity service. Thanks to this new integration, clients will have access to a full white label solution, highly competitive commercials, and a ready-made B2Core integration. This integration is a prime example of B2Broker's dedication to providing its clients with a complete and flexible service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230201005066/en/ Match-Trader White Label Ecosystem (Graphic: Business Wire) Match-Trader While Label Solution To give brokers and their clients a complete Match-Trader experience, B2Broker has created a white label solution. The new service streamlines all necessary technologies into a sing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom